Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jui-Hua Tsai

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Patient Preference and Adherence|May 17, 2018
Research as an event: a novel approach to promote patient-focused drug developmentJui-Hua Tsai, Ellen Janssen, John Fp Bridges
Sensors (Basel, Switzerland)|July 9, 2022
Edge Computing of Online Bounded-Error Query for Energy-Efficient IoT SensorsRay-I Chang, Jui-Hua Tsai, Chia-Hui Wang
MDM Policy & Practice|September 9, 2021
Measuring Meaningful Benefit-Risk Tradeoffs to Promote Patient-Focused Drug Development in Prader-Willi Syndrome: A Discrete-Choice ExperimentJui-Hua Tsai, Norah L Crossnohere, Theresa Strong, et al.
Expert Review of Medical Devices|May 1, 2018
Identifying and prioritizing concerns associated with prosthetic devices for use in a benefit-risk assessment: a mixed-methods approachEllen M Janssen, Heather L Benz, Jui-Hua Tsai, et al.
Advances in Therapy|December 16, 2024
Content Validation of the QOL-B-RD and PROMIS-F SF-7a to Measure Respiratory and Fatigue Symptoms of MAC Lung DiseaseKelly P McCarrier, Mariam Hassan, Dayton W Yuen, et al.
The Patient|September 28, 2018
How Do Members of the Duchenne and Becker Muscular Dystrophy Community Perceive a Discrete-Choice Experiment Incorporating Uncertain Treatment Benefit? An Application of Research as an EventJohn F P Bridges, Jui-Hua Tsai, Ellen Janssen, et al.
Journal of Medical Economics|September 27, 2018
Caregiver priorities for endpoints to evaluate treatments for Prader-Willi syndrome: a best-worst scalingJui-Hua Tsai, Ann O Scheimann, Shawn E McCandless, et al.
Pulmonary Therapy|July 16, 2024
Qualitative Interviews Exploring Adverse Event Mitigation Strategies in Adults Receiving Amikacin Liposome Inhalation SuspensionJuzar Ali, Jasmanda Wu, Mariam Hassan, et al.
Cancer Medicine|October 13, 2022
Understanding what matters to metastatic castration-resistant prostate cancer (mCRPC) patients when considering treatment options: A US patient preference surveyDaniel J George, Ateesha F Mohamed, Jui-Hua Tsai, et al.
Cancer Medicine|July 30, 2020
Patient and caregiver benefit-risk preferences for nonmetastatic castration-resistant prostate cancer treatmentSandy Srinivas, Ateesha F Mohamed, Sreevalsa Appukkuttan, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Patient Preference and Adherence|May 17, 2018
Research as an event: a novel approach to promote patient-focused drug developmentJui-Hua Tsai, Ellen Janssen, John Fp Bridges
Sensors (Basel, Switzerland)|July 9, 2022
Edge Computing of Online Bounded-Error Query for Energy-Efficient IoT SensorsRay-I Chang, Jui-Hua Tsai, Chia-Hui Wang
MDM Policy & Practice|September 9, 2021
Measuring Meaningful Benefit-Risk Tradeoffs to Promote Patient-Focused Drug Development in Prader-Willi Syndrome: A Discrete-Choice ExperimentJui-Hua Tsai, Norah L Crossnohere, Theresa Strong, et al.
Expert Review of Medical Devices|May 1, 2018
Identifying and prioritizing concerns associated with prosthetic devices for use in a benefit-risk assessment: a mixed-methods approachEllen M Janssen, Heather L Benz, Jui-Hua Tsai, et al.
Advances in Therapy|December 16, 2024
Content Validation of the QOL-B-RD and PROMIS-F SF-7a to Measure Respiratory and Fatigue Symptoms of MAC Lung DiseaseKelly P McCarrier, Mariam Hassan, Dayton W Yuen, et al.
The Patient|September 28, 2018
How Do Members of the Duchenne and Becker Muscular Dystrophy Community Perceive a Discrete-Choice Experiment Incorporating Uncertain Treatment Benefit? An Application of Research as an EventJohn F P Bridges, Jui-Hua Tsai, Ellen Janssen, et al.
Journal of Medical Economics|September 27, 2018
Caregiver priorities for endpoints to evaluate treatments for Prader-Willi syndrome: a best-worst scalingJui-Hua Tsai, Ann O Scheimann, Shawn E McCandless, et al.
Pulmonary Therapy|July 16, 2024
Qualitative Interviews Exploring Adverse Event Mitigation Strategies in Adults Receiving Amikacin Liposome Inhalation SuspensionJuzar Ali, Jasmanda Wu, Mariam Hassan, et al.
Cancer Medicine|October 13, 2022
Understanding what matters to metastatic castration-resistant prostate cancer (mCRPC) patients when considering treatment options: A US patient preference surveyDaniel J George, Ateesha F Mohamed, Jui-Hua Tsai, et al.
Cancer Medicine|July 30, 2020
Patient and caregiver benefit-risk preferences for nonmetastatic castration-resistant prostate cancer treatmentSandy Srinivas, Ateesha F Mohamed, Sreevalsa Appukkuttan, et al.
Pageof 2